Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center
Abstract Background Immune checkpoint inhibitors (ICI) have improved outcomes in a variety of adult cancers and are prescribed with increasing frequency across oncology. However, patterns of off‐label use of ICI in pediatrics remain unclear. Methods This is a single‐institution, retrospective cohort...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2024-04-01
|
| Ráidu: | Cancer Medicine |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/cam4.7154 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
